🇺🇸 FDA
Patent

US 11452725

Chiral diaryl macrocycles and uses thereof

granted A61KA61K31/519A61K31/52

Quick answer

US patent 11452725 (Chiral diaryl macrocycles and uses thereof) held by TURNING POINT THERAPEUTICS, INC. expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TURNING POINT THERAPEUTICS, INC.
Grant date
Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/519, A61K31/52, A61P, A61P35/00